Zevra Therapeutics, Inc. Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted
Zevra Therapeutics, Inc. (ZVRA) reported Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted of $18.77 million for the 3-month period ending 2016-06-30, per its 10-Q filed 2017-08-10.
Discontinued › Notes › Earnings Per Share › Earnings Per Share, Diluted, Two Class Method
us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted · last filed 2017-08-10
- Zevra Therapeutics, Inc. participating securities, distributed and undistributed earnings (loss), diluted for the quarter ending 2016-06-30 was $18.77M.
| Period end | Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted 3 month | Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted 6 month |
|---|---|---|
| 2016-06-30 | $18.77M 10-Q · filed 2017-08-10 | $28.00M 10-Q · filed 2017-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |